Dr. Natalie Dean in Wired
Dr. Natalie Dean clears some of the confusion about ‘asymptomatic’ COVID-19 and its connection to spreading the virus.
Posted in
In The Media
Dr. Sonal Tuli in AARP Health
Dr. Sonal Tuli discusses infection pathways for novel coronavirus.
Dr. Natalie Dean in Politifact
Dr. Natalie Dean discusses some of the current statistics regarding COVID-19 infection rates and the dangers of waiting for herd immunity.
Dr. David Nelson in Orlando Sentinel
Dr. David Nelson, UF’s senior vice president for health affairs, discusses some of the screening and testing necessary to re-open the University of Florida to students.
Dr. Merry-Jennifer Markham in Forbes
Merry-Jennifer Markham, MD, FACP, FASCO, an oncologist at University of Florida, discusses the uncertainty some might feel about cancer screenings in the time of COVID-19.
Piyush K. Jain pens article for Fast Company
Piyush K. Jain, Ph.D., an assistant professor in the Department of Chemical Engineering and a member of the UF Health Cancer Center, explains why CRISPR might be the key for at-home coronavirus tests.
CNN talks to Drs. Kartic Cherabuddi and Juan Vilaro
Dr. Kartic Cherabuddi and Dr. Juan Vilaro discuss the complicated case of Enell “Trent” Porter who survived heart and kidney transplants, and then Covid-19.
Dr. Scott Brakenridge on CNN
Dr. Scott Brakenridge discusses evolving discoveries about novel coronavirus’ behavior, including the various ways it attacks its hosts.
Sonja Rasmussen in New Scientist
Sonha Rasmussen warns pregnant women to avoid getting coronavirus, saying we don’t yet know the full implications of infection…
Dr. Natalie Dean interviewed by Slate’s What Next: TBD podcast
Natalie Dean, Ph.D., discusses the overarching benefits of antibody testing. She details the scientific and public benefits that come with rigorous, wide-spread testing efforts.